A randomized double blind placebo controlled trial was carried out to investigate the efficacy of T. crispa as an additional treatment in patients with type 2 diabetes mellitus who refused insulin injection and did not respond to oral hypoglycemic drugs (Sangsuwan et al., 2004). This evidence concerns the gene INS and type 2 diabetes mellitus.